# Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors

> **NCT00003768** · PHASE1 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 25 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** fosbretabulin disodium

## Key facts

- **NCT ID:** NCT00003768
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2001-07
- **Final completion:** 2001-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003768, "Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*